Mazumdar Claire: insider trades.
Mazumdar Claire reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($564K), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Mazumdar Claire
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Bicara Therapeutics Inc. (BCAX) | Director, Officer · Chief Executive Officer | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-10 | Bicara Therapeutics Inc. | S | 10,000 | $27.98 | 362,152 | Form 4 |
| 2026-08-10 | Bicara Therapeutics Inc. | M | 10,000 | $3.79 | 372,152 | Form 4 |
| 2026-07-10 | Bicara Therapeutics Inc. | M | 10,000 | $3.79 | 372,152 | Form 4 |
| 2026-07-10 | Bicara Therapeutics Inc. | S | 9,972 | $28.42 | 362,180 | Form 4 |
| 2026-07-10 | Bicara Therapeutics Inc. | S | 28 | $29.68 | 362,152 | Form 4 |
Questions
What stock did Mazumdar Claire buy or sell?
Mazumdar Claire reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($564K), across 1 company.
Is Mazumdar Claire the same person as other filers with this name?
This page covers SEC CIK 2034671 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/mazumdar-claire-2034671.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.